Q&A: GSK CSO Tony Wood on stay­ing out of obe­si­ty, 'care­ful' can­cer am­bi­tions, and AI's fu­ture in R&D

When Tony Wood be­came GSK’s top sci­en­tist in mid-2022, the British phar­ma was wag­ing bat­tle.

GSK was fight­ing Zan­tac-re­lat­ed lit­i­ga­tion in court while strug­gling to …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER